EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome

Abstract

Objective: To develop a disease activity index for patients with primary Sjögren's syndrome (SS): the European League Against Rheumatism (EULAR) Sjögren's syndrome disease activity index (ESSDAI).

Methods: Thirty-nine SS experts participated in an international collaboration, promoted by EULAR, to develop the ESSDAI. Experts identified 12 organ-specific 'domains' contributing to disease activity. For each domain, features of disease activity were classified in three or four levels according to their severity. Data abstracted from 96 patients with systemic complications of primary SS were used to generate 702 realistic vignettes for which all possible systemic complications were represented. Using the 0-10 physician global assessment (PhGA) scale, each expert scored the disease activity of five patient profiles and 20 realistic vignettes. Multiple regression modelling, with PhGA used as the dependent variable, was used to estimate the weight of each domain.

Results: All 12 domains were significantly associated with disease activity in the multivariate model, domain weights ranged from 1 to 6. The ESSDAI scores varied from 2 to 47 and were significantly correlated with PhGA for both real patient profiles and realistic vignettes (r=0.61 and r=0.58, respectively, p<0.001). Compared with 57 (59.4%) of the real patient profiles, 468 (66.7%) of the realistic vignettes were considered likely or very likely to be true.

Conclusions: The ESSDAI is a clinical index designed to measure disease activity in patients with primary SS. Once validated, such a standardised evaluation of primary SS should facilitate clinical research and be helpful as an outcome measure in clinical trials.

Figures

Figure 1. Distribution of ESSDAI scores and correlation with disease activity in real patient profiles and realistic vignettes

Figures 2A, 2B, 2C refer to the 702 realistic clinical vignettes, and figures 2D, 2E, 2F refer to the 96 real patient profiles. Distribution of ESSDAI scores in realistic vignettes (A) and real patient profiles (D), ESSDAI score for each level of global activity as defined by physicians on the 5-point scale (B and E), and correlation between ESSDAI scores and physicians’ ratings of disease activity by the physician global assessment (PhGA) scale (0–10 scale) (C and F). For box plots of ESSDAI scores, the boxes represent the 25th and 75th percentiles; the lines within the box represent the median; the dot inside the box, linked by a line, represents the mean; and the whiskers extend to the most extreme data point, which is no more than 1.5 times the interquartile range (difference between the 75th and 25th percentiles) from the box. Values that are more extreme were considered outliers and are plotted individually (dots).